United States:
Repeal of the McCarran Ferguson Act: On Ramp or Speed Bump Along the Highway of Health Care Reform
02 June 2017
Carlton Fields
To print this article, all you need is to be registered or login on Mondaq.com.
You can rest assured that the national conversation on health
care reform is far from over. The campaign mantra of "repeal
and replace" seems to have over-shadowed other potential
avenues for reforming U.S. health care policy: including repealing
the McCarran Ferguson Act (Act) as it applies to health
insurance.
Click here to view the original article in its
entirety
Originally published by AHLA Connections, May 2017
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
